Evidence map›Paper›PMID 39595094›Full record

ReviewBiomedicines2024

Emerging Mechanisms of Physical Exercise Benefits in Adjuvant and Neoadjuvant Cancer Immunotherapy.

Fabio Casciano, Lorenzo Caruso, Enrico Zauli, Arianna Gonelli, Giorgio Zauli, Mauro Vaccarezza

Abstract readReview
In one paragraph

Review in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fabio CascianoDepartment of Environmental Sciences and Prevention and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0002-6431-3335
Lorenzo CarusoDepartment of Environmental Sciences and Prevention, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0001-9895-3990
Enrico ZauliDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
Arianna GonelliDepartment of Environmental Sciences and Prevention, University of Ferrara, 44121 Ferrara, Italy.
Giorgio ZauliResearch Department, King Khaled Eye Specialistic Hospital, Riyadh 12329, Saudi Arabia.
Mauro VaccarezzaDepartment of Environmental Sciences and Prevention, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0003-3060-318X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The primary factors that can be modified in one's lifestyle are the most influential determinants and significant preventable causes of various types of cancer. Exercise has demonstrated numerous advantages in preventing cancer and aiding in its treatment. However, the precise mechanisms behind these effects are still not fully understood. To contribute to our comprehension of exercise's impact on cancer immunotherapy and provide recommendations for future research in exercise oncology, we will examine the roles and underlying mechanisms of exercise on immune cells. In addition to reducing the likelihood of developing cancer, exercise can also improve the effectiveness of certain approved anticancer treatments, such as targeted therapy, immunotherapy, and radiotherapy. Exercise is a pivotal modulator of the immune response, and thus, it can play an emerging important role in new immunotherapies. The mechanisms responsible for these effects involve the regulation of intra-tumoral angiogenesis, myokines, adipokines, their associated pathways, cancer metabolism, and anticancer immunity. Our review assesses the potential of physical exercise as an adjuvant/neoadjuvant tool, reducing the burden of cancer relapse, and analyzes emerging molecular mechanisms predicting favorable adjuvanticity effects.

Indexed as

immune responseimmunotherapylifestyleoncologyphysical exercisetumor microenvironment

Identifiers

PMID39595094
PMCPMC11591576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.